|
QuintilesIMS Real-World Insights Bibliography
| Orphan Drug Expenditures In The United States: A Historical And Prospective Analysis, 2007-18. |
| Author(s): Divino V1, DeKoven M2, Kleinrock M3, Wade RL4, Kaura S5. |
| Affiliations(s): 1 Victoria Divino (vdivino@us.imshealth.com) is a senior consultant at IMS Health in Fairfax, Virginia.
2 Mitch DeKoven is a principal at IMS Health.
3 Michael Kleinrock is director of research development for the IMS Institute for Healthcare Informatics, in Parsippany, New Jersey.
4 Rolin L. Wade is a senior principal at IMS Health.
5 Satyin Kaura is a senior director at Celgene Corporation, in Summit, New Jersey. |
| Publication(s): Health Aff (Millwood). 2016 Sep 1;35(9):1588-94 |
| Document Type(s): Article |
| Countries: USA |
C:
Y: |
Rare Diseases
2016 |
|
L:
A: |
English
Budget impact |
|
 |
| |
| |
| Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007-13) and prospective (2014-18) MIDAS sales data analysis. |
| Author(s): Divino V1, DeKoven M2, Kleinrock M3, Wade RL2, Kim T4, Kaura S5. |
| Affiliations(s): 1 IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax, VA, 22031, USA. vdivino@us.imshealth.com.
2 IMS Health, 8280 Willow Oaks Corporate Drive, Suite 775, Fairfax, VA, 22031, USA.
3 IMS Institute for Healthcare Informatics, One IMS Drive, Plymouth Meeting, PA, 19462, USA.
4 Celgene, 6755 Mississauga Rd, Suite 600, Mississauga, ON, L5N 7Y2, Canada.
5 Celgene, 86 Morris Avenue, H-222H, Summit, NJ, 07901, USA. |
| Publication(s): Orphanet J Rare Dis. 2016 May 21;11(1):68 |
| Document Type(s): Article |
| Countries: Canada |
| Click here for the abstract |
C:
Y: |
Rare Diseases
2016 |
|
L:
A: |
English
Budget impact |
|
|
| |
| |
|
|
|
